CXCL12 and melanoma: Findings are consistent with Bartolome et al's previous report, which showed that RhoA activity was enhanced in murine B16F10 melanoma cells upon SDF-1 stimulation [12] and involved the two Rho-GTPase guanine-nucleotide exchange factors Vav1 and Vav2 [13].